Advanced search
Publication Cover
Journal of Chemotherapy Volume 25, 2013 - Issue 1
Submit an article Journal homepage
93
Views
0
CrossRef citations to date
0
Altmetric
Anticancer Original Research Paper

Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial

Ting Deng Department of Gastrointestinal Medical OncologyTianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Cancer Prevention and Therapy of Tianjin, China
,
Nong Xu Department of OncologyThe First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, China
,
Jian-Ping Xiong Department of OncologyThe First Affiliated Hospital of Nanchang University, China
,
Zhao Yan Department of Clinical pharmacologyTianjin Medical University Cancer Institute and Hospital, China
,
Zhi-Xiang Zhuang Department of OncologyThe Second Affiliated Hospital of Soochow University, China
,
Zhuang Yu Department of OncologyThe Affiliated Hospital of Medical College Qingdao University, China
,
Hui-Ping WanDepartment of Oncology People’s Hospital of Jiangxi Province, Nanchang, China
,
Yang Zhang Department of OncologyThe Second Affiliated Hospital of Dalian Medical University, China
,
Ding-Zhi Huang Department of Gastrointestinal Medical OncologyTianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Cancer Prevention and Therapy of Tianjin, China
,
Rong-Sheng Zheng Department of OncologyThe First Affiliated Hospital of Bengbu Medical College, China
,
Zeng-Qing GuoDepartment of Oncology, Fujian Province Cancer Hospital, Fuzhou, China
,
Chun-Hong HuDepartment of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China
,
Mei-Ling WangDepartment of Oncology, The Third People’s Hospital of Shanghai Jiao Tong University School of Medicine, China
,
Zhong-He YuDepartment of Oncology, The Military General Hospital of Beijing PLA, China
,
Yang YaoDepartment of Oncology, Shanghai 6th People’s Hospital`, China
,
Ji-Chang MengDepartment of Oncology, Bethune International Peace Hospital of The People’bs Liberation Army, Shijiazhuang, China
&
Yi Ba Department of Gastrointestinal Medical OncologyTianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Cancer Prevention and Therapy of Tianjin, ChinaCorrespondence[email protected]
 show all
Pages 56-59 | Published online: 12 Nov 2013

References

  • Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467–77.
  • Rebecca S, Elizabeth W, Otis B, Ahmedin J. Cancer statistics, 2011. CA Cancer J Clin. 2011;61:212–36.
  • van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al.. V325 Study Group: phase III study of docetaxel and cisplatin plus fuorouracil compared with cisplatin and fuorouracil as frst-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol. 2006,24:4991–7.
  • Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al.. Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom: capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008,358:36–46.
  • Huang TC, Campbell TC. Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: a meta-analysis. Cancer Treat Rev. 2012;38(6):613–7.
  • Kang HJ, Chang HM, Kim TW, Ryu MH, Sohn HJ, Yook JH, et al.. A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer. Br J Cancer. 2008,98(2):316–22.
  • Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, et al.. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs. 1996;7(5):548–57.
  • Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, et al.. Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group: fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10(11):1063–9.
  • Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al.. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215–21.
  • Nakajo A, Hokita S, Ishigami S, Miyazono F, Etoh T, Hamanoue M, et al.. Kyushu Taxol TS-1 Study Group: a multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer. Cancer Chemother Pharmacol. 2008;62(6):1103–9.
  • Lee JJ, Kim SY, Chung HC, Lee KH, Song HS, Kang WK, et al.. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer. Cancer Chemother Pharmacol. 2009;63(6):1083–90.
  • Ueda Y, Yamagishi H, Ichikawa D, Okamoto K, Otsuji E, Morii J, et al.. Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer. Gastric Cancer. 2010;13(3):149–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.